SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Bhatta S, Awasthi PR. Clin. Case Rep. 2024; 12(4): e8767.

Copyright

(Copyright © 2024, John Wiley and Sons)

DOI

10.1002/ccr3.8767

PMID

38595966

PMCID

PMC11002105

Abstract

KEY CLINICAL MESSAGE: Nitrobenzene poisoning is a rare yet life-threatening contention. The ensuing acute methemoglobinemia has a high fatality rate, hence early prompt intervention is required. Methylene blue (intravenous or oral) and ascorbic acid are the cornerstones of management. They must be administered to suspected patients without tardiness.

ABSTRACT: An aromatic organic chemical used in paints and the printing industry is nitrobenzene. Its poisoning causes potentially fatal methemoglobinemia. One aspect of its management involves reducing the iron moiety from its ferric to ferrous form by administering intravenous methylene blue. A 23-year-old man who had deliberately consumed nitrobenzene presented to us with a history of headache and vomiting. He was diagnosed to have methemoglobinemia on the basis of clinical grounds and was managed successfully with intravenous methylene blue and vitamin C.


Language: en

Keywords

ascorbic acid; methemoglobinemia; methylene blue; nitrobenzene; poisoning

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print